Cargando…

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease

The pathological hallmarks of Parkinson’s disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an ascending manner throughout the brain as the disease progresses....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekiya, Hiroaki, Tsuji, Asato, Hashimoto, Yuki, Takata, Mariko, Koga, Shunsuke, Nishida, Katsuya, Futamura, Naonobu, Kawamoto, Michi, Kohara, Nobuo, Dickson, Dennis W., Kowa, Hisatomo, Toda, Tatsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450240/ https://www.ncbi.nlm.nih.gov/pubmed/36068646 http://dx.doi.org/10.1186/s40478-022-01440-6

Ejemplares similares

Two Cases of Acute Disseminated Encephalomyelitis Following Vaccination Against Human Papilloma Virus
por: Sekiguchi, Kenji, et al.
Publicado: (2016)

Validation of the R(2)CHADS(2) and CHADS(2) Scores for Predicting Post-stroke Cognitive Impairment
por: Washida, Kazuo, et al.
Publicado: (2017)

Regional glucose hypometabolic spread within the primary motor cortex is associated with amyotrophic lateral sclerosis disease progression: A fluoro-deoxyglucose positron emission tomography study
por: Endo, Hironobu, et al.
Publicado: (2017)

Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
por: Ingelsson, Martin
Publicado: (2016)

Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease
por: Yamamoto, Kenji
Publicado: (2021)

Two Lambert-Eaton Myasthenic Syndrome Patients with Ameliorated Activities of Daily Living Due to Cholinesterase Inhibitors
por: Yamasaki, Hiroshi, et al.
Publicado: (2021)

Post-hyperventilation Apnea with Spindle Activity on Electroencephalogram
por: Ueda, Jun, et al.
Publicado: (2018)

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
por: Umeda, Tomohiro, et al.
Publicado: (2021)

Galectin 3–binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein
por: Seki, Tsuneyoshi, et al.
Publicado: (2020)

Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab
por: Kawamoto, Michi, et al.
Publicado: (2018)

A case report of fulminant cytokine release syndrome complicated by dermatomyositis after the combination therapy with immune checkpoint inhibitors
por: Ohira, Junichiro, et al.
Publicado: (2020)

Post COVID-19 Bilateral Facial Nerve Palsy
por: Inui, Ryoma, et al.
Publicado: (2021)

Lighting Up Alpha-synuclein Oligomers
por: Richter, Franziska
Publicado: (2018)

Injection of Onabotulinum Toxin A into the Bilateral External Oblique Muscle Attenuated Camptocormia: A Prospective Open-Label Study in Six Patients with Parkinson’s Disease
por: Todo, Hiroyuki, et al.
Publicado: (2018)

Count of Fasciculation in Ultrasound Can Predict the Prognosis of Amyotrophic Lateral Sclerosis
por: Todo, Hiroyuki, et al.
Publicado: (2019)

Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC
por: Sano, Kazunori, et al.
Publicado: (2017)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2014)

High-dose immunoglobulin-dependent chronic demyelinating inflammatory polyneuropathy successfully managed with subcutaneous immunoglobulin using pharmacokinetic analysis
por: Hiya, Satomi, et al.
Publicado: (2022)

Direct detection of alpha synuclein oligomers in vivo
por: Dimant, Hemi, et al.
Publicado: (2013)

Alpha-synuclein oligomers: a new hope
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2017)

Quantifying Co-Oligomer Formation by α-Synuclein
por: Iljina, Marija, et al.
Publicado: (2018)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Stabilization of α-synuclein oligomers using formaldehyde
por: Ruesink, Harm, et al.
Publicado: (2019)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
por: Danzer, Karin M, et al.
Publicado: (2012)

Structural and functional properties of prefibrillar α-synuclein oligomers
por: Pieri, Laura, et al.
Publicado: (2016)

Optical Structural Analysis of Individual α‐Synuclein Oligomers
por: Varela, Juan A., et al.
Publicado: (2018)

Mapping Surface Hydrophobicity of α-Synuclein Oligomers at the Nanoscale
por: Lee, Ji-Eun, et al.
Publicado: (2018)

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
por: Vaikath, Nishant, et al.
Publicado: (2022)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
por: Bigi, Alessandra, et al.
Publicado: (2023)

Eribulin Mesylate-related Multifocal Demyelinating Neuropathy with Myokymia in a Breast Cancer Patient
por: Tsunogae, Marie, et al.
Publicado: (2021)

Authors Response: Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19
por: Ishiyama, Hiroyuki, et al.
Publicado: (2022)

Japanese WDR45 de novo mutation diagnosed by exome analysis: A case report
por: Endo, Hironobu, et al.
Publicado: (2017)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

Structural characteristics and membrane interactions of tandem α-synuclein oligomers
por: Dong, Chunhua, et al.
Publicado: (2018)

Photo-Induced Cross-Linking of Unmodified α-Synuclein Oligomers
por: Ortigosa-Pascual, Lei, et al.
Publicado: (2023)

DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein
por: Atieh, Tamr B., et al.
Publicado: (2021)

Favorable Outcome with Intravenous Immunoglobulin Therapy in Late-Onset Anti-mGluR1 Encephalitis: A Case Report and Literature Review
por: Sakashita, Kento, et al.
Publicado: (2023)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

α-Synuclein Oligomers Induced by Docosahexaenoic Acid Affect Membrane Integrity
por: Fecchio, Chiara, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_751sdntj5o1qphqgkle4urblgg